Advertisement

Index by author

July 01, 1989; Volume 36,Issue 1

A

  1. Aoyama, T

    1. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.
      S Yamano, T Aoyama, O W McBride, J P Hardwick, H V Gelboin and F J Gonzalez
      Molecular Pharmacology July 1989, 36 (1) 83-88;

  2. Aronstam, R S

    1. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
      C E Spivak, J A Waters and R S Aronstam
      Molecular Pharmacology July 1989, 36 (1) 177-184;

B

  1. Bailey, J C

    1. Selective parasympathectomy increases the quantity of inhibitory guanine nucleotide-binding proteins in canine cardiac ventricle.
      T D Hodges, J C Bailey, J W Fleming and R J Kovacs
      Molecular Pharmacology July 1989, 36 (1) 72-77;

  2. Brown, J H

    1. Thrombin and trypsin act at the same site to stimulate phosphoinositide hydrolysis and calcium mobilization.
      L G Jones, P M McDonough and J H Brown
      Molecular Pharmacology July 1989, 36 (1) 142-149;

  3. Burch, R M

    1. Evidence for a pulmonary B3 bradykinin receptor.
      S G Farmer, R M Burch, S A Meeker and D E Wilkins
      Molecular Pharmacology July 1989, 36 (1) 1-8;

C

  1. Carlisle, R

    1. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
      J P Sommadossi, R Carlisle and Z Zhou
      Molecular Pharmacology July 1989, 36 (1) 9-14;

  2. Caron, M G

    1. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
      J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron
      Molecular Pharmacology July 1989, 36 (1) 15-21;

  3. Cheng, Y C

    1. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
      S Y Liu, B D Hwang, M Haruna, Y Imakura, K H Lee and Y C Cheng
      Molecular Pharmacology July 1989, 36 (1) 78-82;

  4. Coleman, J B

    1. Dissociation of the accumulation of single-strand breaks in DNA from the killing of cultured hepatocytes by an oxidative stress.
      J B Coleman, D Gilfor and J L Farber
      Molecular Pharmacology July 1989, 36 (1) 193-200;

  5. Coon, M J

    1. Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes.
      T D Porter, S C Khani and M J Coon
      Molecular Pharmacology July 1989, 36 (1) 61-65;

  6. Costa, E

    1. Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.
      H Manev, M Favaron, A Guidotti and E Costa
      Molecular Pharmacology July 1989, 36 (1) 106-112;

  7. Cowan, K H

    1. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
      J A Moscow, A J Townsend and K H Cowan
      Molecular Pharmacology July 1989, 36 (1) 22-28;

  8. Creese, I

    1. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
      M A Riva and I Creese
      Molecular Pharmacology July 1989, 36 (1) 201-210;
    2. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
      M A Riva and I Creese
      Molecular Pharmacology July 1989, 36 (1) 211-218;

D

  1. Daly, J W

    1. Calcium-dependent effects of maitotoxin on phosphoinositide breakdown and on cyclic AMP accumulation in PC12 and NCB-20 cells.
      F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology July 1989, 36 (1) 44-53;

  2. Dean, J H

    1. Molecular mechanism of 7,12-dimethylbenz[a]anthracene-induced immunosuppression: evidence for action via the interleukin-2 pathway.
      M J Pallardy, R V House and J H Dean
      Molecular Pharmacology July 1989, 36 (1) 128-133;

  3. Denney, R M

    1. Characterization and quantitation of monoamine oxidases A and B in mitochondria from human placenta.
      L A Riley, M A Waguespack and R M Denney
      Molecular Pharmacology July 1989, 36 (1) 54-60;

  4. Duff, H J

    1. Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
      R J Hill, H J Duff and R S Sheldon
      Molecular Pharmacology July 1989, 36 (1) 150-159;

F

  1. Falany, C N

    1. Immunological characterization of human phenol sulfotransferase.
      J A Heroux, C N Falany and J A Roth
      Molecular Pharmacology July 1989, 36 (1) 29-33;

  2. Farber, J L

    1. Dissociation of the accumulation of single-strand breaks in DNA from the killing of cultured hepatocytes by an oxidative stress.
      J B Coleman, D Gilfor and J L Farber
      Molecular Pharmacology July 1989, 36 (1) 193-200;

  3. Fargin, A

    1. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
      J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron
      Molecular Pharmacology July 1989, 36 (1) 15-21;

  4. Farmer, S G

    1. Evidence for a pulmonary B3 bradykinin receptor.
      S G Farmer, R M Burch, S A Meeker and D E Wilkins
      Molecular Pharmacology July 1989, 36 (1) 1-8;

  5. Favaron, M

    1. Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.
      H Manev, M Favaron, A Guidotti and E Costa
      Molecular Pharmacology July 1989, 36 (1) 106-112;

  6. Fleming, J W

    1. Selective parasympathectomy increases the quantity of inhibitory guanine nucleotide-binding proteins in canine cardiac ventricle.
      T D Hodges, J C Bailey, J W Fleming and R J Kovacs
      Molecular Pharmacology July 1989, 36 (1) 72-77;

G

  1. Gati, W P

    1. Interaction of [3H]dilazep at nucleoside transporter-associated binding sites on S49 mouse lymphoma cells.
      W P Gati and A R Paterson
      Molecular Pharmacology July 1989, 36 (1) 134-141;

  2. Gelboin, H V

    1. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.
      S Yamano, T Aoyama, O W McBride, J P Hardwick, H V Gelboin and F J Gonzalez
      Molecular Pharmacology July 1989, 36 (1) 83-88;

  3. Gilfor, D

    1. Dissociation of the accumulation of single-strand breaks in DNA from the killing of cultured hepatocytes by an oxidative stress.
      J B Coleman, D Gilfor and J L Farber
      Molecular Pharmacology July 1989, 36 (1) 193-200;

  4. Glover, E

    1. [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification.
      A Poland, P Teitelbaum and E Glover
      Molecular Pharmacology July 1989, 36 (1) 113-120;
    2. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
      A Poland, P Teitelbaum, E Glover and A Kende
      Molecular Pharmacology July 1989, 36 (1) 121-127;

  5. Gonzalez, F J

    1. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.
      S Yamano, T Aoyama, O W McBride, J P Hardwick, H V Gelboin and F J Gonzalez
      Molecular Pharmacology July 1989, 36 (1) 83-88;
    2. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
      T Kronbach, D Mathys, M Umeno, F J Gonzalez and U A Meyer
      Molecular Pharmacology July 1989, 36 (1) 89-96;

  6. Guidotti, A

    1. Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.
      H Manev, M Favaron, A Guidotti and E Costa
      Molecular Pharmacology July 1989, 36 (1) 106-112;

  7. Gusovsky, F

    1. Calcium-dependent effects of maitotoxin on phosphoinositide breakdown and on cyclic AMP accumulation in PC12 and NCB-20 cells.
      F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology July 1989, 36 (1) 44-53;

H

  1. Hardwick, J P

    1. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.
      S Yamano, T Aoyama, O W McBride, J P Hardwick, H V Gelboin and F J Gonzalez
      Molecular Pharmacology July 1989, 36 (1) 83-88;

  2. Haruna, M

    1. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
      S Y Liu, B D Hwang, M Haruna, Y Imakura, K H Lee and Y C Cheng
      Molecular Pharmacology July 1989, 36 (1) 78-82;

  3. Hashimoto, K

    1. Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+ influx.
      G Tsujimoto, A Tsujimoto, E Suzuki and K Hashimoto
      Molecular Pharmacology July 1989, 36 (1) 166-176;

  4. Heroux, J A

    1. Immunological characterization of human phenol sulfotransferase.
      J A Heroux, C N Falany and J A Roth
      Molecular Pharmacology July 1989, 36 (1) 29-33;

  5. Hill, R J

    1. Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
      R J Hill, H J Duff and R S Sheldon
      Molecular Pharmacology July 1989, 36 (1) 150-159;

  6. Hodges, T D

    1. Selective parasympathectomy increases the quantity of inhibitory guanine nucleotide-binding proteins in canine cardiac ventricle.
      T D Hodges, J C Bailey, J W Fleming and R J Kovacs
      Molecular Pharmacology July 1989, 36 (1) 72-77;

  7. House, R V

    1. Molecular mechanism of 7,12-dimethylbenz[a]anthracene-induced immunosuppression: evidence for action via the interleukin-2 pathway.
      M J Pallardy, R V House and J H Dean
      Molecular Pharmacology July 1989, 36 (1) 128-133;

  8. Hwang, B D

    1. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
      S Y Liu, B D Hwang, M Haruna, Y Imakura, K H Lee and Y C Cheng
      Molecular Pharmacology July 1989, 36 (1) 78-82;

I

  1. Imakura, Y

    1. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
      S Y Liu, B D Hwang, M Haruna, Y Imakura, K H Lee and Y C Cheng
      Molecular Pharmacology July 1989, 36 (1) 78-82;

J

  1. Jones, L G

    1. Thrombin and trypsin act at the same site to stimulate phosphoinositide hydrolysis and calcium mobilization.
      L G Jones, P M McDonough and J H Brown
      Molecular Pharmacology July 1989, 36 (1) 142-149;

K

  1. Kende, A

    1. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
      A Poland, P Teitelbaum, E Glover and A Kende
      Molecular Pharmacology July 1989, 36 (1) 121-127;

  2. Khani, S C

    1. Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes.
      T D Porter, S C Khani and M J Coon
      Molecular Pharmacology July 1989, 36 (1) 61-65;

  3. Kovacs, R J

    1. Selective parasympathectomy increases the quantity of inhibitory guanine nucleotide-binding proteins in canine cardiac ventricle.
      T D Hodges, J C Bailey, J W Fleming and R J Kovacs
      Molecular Pharmacology July 1989, 36 (1) 72-77;

  4. Kronbach, T

    1. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
      T Kronbach, D Mathys, M Umeno, F J Gonzalez and U A Meyer
      Molecular Pharmacology July 1989, 36 (1) 89-96;

L

  1. Lee, K H

    1. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
      S Y Liu, B D Hwang, M Haruna, Y Imakura, K H Lee and Y C Cheng
      Molecular Pharmacology July 1989, 36 (1) 78-82;

  2. Lefkowitz, R J

    1. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
      J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron
      Molecular Pharmacology July 1989, 36 (1) 15-21;

  3. Liu, S Y

    1. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
      S Y Liu, B D Hwang, M Haruna, Y Imakura, K H Lee and Y C Cheng
      Molecular Pharmacology July 1989, 36 (1) 78-82;

  4. Lohse, M J

    1. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
      J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron
      Molecular Pharmacology July 1989, 36 (1) 15-21;

  5. Loo, P S

    1. Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and L-glutamate.
      M A Sills and P S Loo
      Molecular Pharmacology July 1989, 36 (1) 160-165;

M

  1. Manev, H

    1. Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.
      H Manev, M Favaron, A Guidotti and E Costa
      Molecular Pharmacology July 1989, 36 (1) 106-112;

  2. Mathys, D

    1. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
      T Kronbach, D Mathys, M Umeno, F J Gonzalez and U A Meyer
      Molecular Pharmacology July 1989, 36 (1) 89-96;

  3. McBride, O W

    1. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.
      S Yamano, T Aoyama, O W McBride, J P Hardwick, H V Gelboin and F J Gonzalez
      Molecular Pharmacology July 1989, 36 (1) 83-88;

  4. McDonough, P M

    1. Thrombin and trypsin act at the same site to stimulate phosphoinositide hydrolysis and calcium mobilization.
      L G Jones, P M McDonough and J H Brown
      Molecular Pharmacology July 1989, 36 (1) 142-149;

  5. Meeker, S A

    1. Evidence for a pulmonary B3 bradykinin receptor.
      S G Farmer, R M Burch, S A Meeker and D E Wilkins
      Molecular Pharmacology July 1989, 36 (1) 1-8;

  6. Meyer, U A

    1. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
      T Kronbach, D Mathys, M Umeno, F J Gonzalez and U A Meyer
      Molecular Pharmacology July 1989, 36 (1) 89-96;

  7. Moscow, J A

    1. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
      J A Moscow, A J Townsend and K H Cowan
      Molecular Pharmacology July 1989, 36 (1) 22-28;

N

  1. Nathanson, J A

    1. Development of a photoaffinity ligand for octopamine receptors.
      J A Nathanson
      Molecular Pharmacology July 1989, 36 (1) 34-43;

P

  1. Pallardy, M J

    1. Molecular mechanism of 7,12-dimethylbenz[a]anthracene-induced immunosuppression: evidence for action via the interleukin-2 pathway.
      M J Pallardy, R V House and J H Dean
      Molecular Pharmacology July 1989, 36 (1) 128-133;

  2. Paterson, A R

    1. Interaction of [3H]dilazep at nucleoside transporter-associated binding sites on S49 mouse lymphoma cells.
      W P Gati and A R Paterson
      Molecular Pharmacology July 1989, 36 (1) 134-141;

  3. Plagemann, P G

    1. Permeation and salvage of dideoxyadenosine in mammalian cells.
      P G Plagemann and C Woffendin
      Molecular Pharmacology July 1989, 36 (1) 185-192;

  4. Poland, A

    1. [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification.
      A Poland, P Teitelbaum and E Glover
      Molecular Pharmacology July 1989, 36 (1) 113-120;
    2. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
      A Poland, P Teitelbaum, E Glover and A Kende
      Molecular Pharmacology July 1989, 36 (1) 121-127;

  5. Porter, T D

    1. Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes.
      T D Porter, S C Khani and M J Coon
      Molecular Pharmacology July 1989, 36 (1) 61-65;

Q

  1. Quattrochi, L C

    1. The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene.
      L C Quattrochi and R H Tukey
      Molecular Pharmacology July 1989, 36 (1) 66-71;

R

  1. Raymond, J R

    1. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
      J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron
      Molecular Pharmacology July 1989, 36 (1) 15-21;

  2. Regan, J W

    1. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
      J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron
      Molecular Pharmacology July 1989, 36 (1) 15-21;

  3. Riley, L A

    1. Characterization and quantitation of monoamine oxidases A and B in mitochondria from human placenta.
      L A Riley, M A Waguespack and R M Denney
      Molecular Pharmacology July 1989, 36 (1) 54-60;

  4. Ring, B J

    1. Identification of a polymorphically expressed member of the human cytochrome P-450III family.
      S A Wrighton, B J Ring, P B Watkins and M VandenBranden
      Molecular Pharmacology July 1989, 36 (1) 97-105;

  5. Riva, M A

    1. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
      M A Riva and I Creese
      Molecular Pharmacology July 1989, 36 (1) 201-210;
    2. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
      M A Riva and I Creese
      Molecular Pharmacology July 1989, 36 (1) 211-218;

  6. Roth, J A

    1. Immunological characterization of human phenol sulfotransferase.
      J A Heroux, C N Falany and J A Roth
      Molecular Pharmacology July 1989, 36 (1) 29-33;

S

  1. Senogles, S E

    1. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
      J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron
      Molecular Pharmacology July 1989, 36 (1) 15-21;

  2. Sheldon, R S

    1. Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
      R J Hill, H J Duff and R S Sheldon
      Molecular Pharmacology July 1989, 36 (1) 150-159;

  3. Sills, M A

    1. Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and L-glutamate.
      M A Sills and P S Loo
      Molecular Pharmacology July 1989, 36 (1) 160-165;

  4. Sommadossi, J P

    1. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
      J P Sommadossi, R Carlisle and Z Zhou
      Molecular Pharmacology July 1989, 36 (1) 9-14;

  5. Spivak, C E

    1. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
      C E Spivak, J A Waters and R S Aronstam
      Molecular Pharmacology July 1989, 36 (1) 177-184;

  6. Suzuki, E

    1. Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+ influx.
      G Tsujimoto, A Tsujimoto, E Suzuki and K Hashimoto
      Molecular Pharmacology July 1989, 36 (1) 166-176;

T

  1. Teitelbaum, P

    1. [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification.
      A Poland, P Teitelbaum and E Glover
      Molecular Pharmacology July 1989, 36 (1) 113-120;
    2. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
      A Poland, P Teitelbaum, E Glover and A Kende
      Molecular Pharmacology July 1989, 36 (1) 121-127;

  2. Townsend, A J

    1. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
      J A Moscow, A J Townsend and K H Cowan
      Molecular Pharmacology July 1989, 36 (1) 22-28;

  3. Tsujimoto, A

    1. Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+ influx.
      G Tsujimoto, A Tsujimoto, E Suzuki and K Hashimoto
      Molecular Pharmacology July 1989, 36 (1) 166-176;

  4. Tsujimoto, G

    1. Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+ influx.
      G Tsujimoto, A Tsujimoto, E Suzuki and K Hashimoto
      Molecular Pharmacology July 1989, 36 (1) 166-176;

  5. Tukey, R H

    1. The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene.
      L C Quattrochi and R H Tukey
      Molecular Pharmacology July 1989, 36 (1) 66-71;

U

  1. Umeno, M

    1. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
      T Kronbach, D Mathys, M Umeno, F J Gonzalez and U A Meyer
      Molecular Pharmacology July 1989, 36 (1) 89-96;

V

  1. VandenBranden, M

    1. Identification of a polymorphically expressed member of the human cytochrome P-450III family.
      S A Wrighton, B J Ring, P B Watkins and M VandenBranden
      Molecular Pharmacology July 1989, 36 (1) 97-105;

W

  1. Waguespack, M A

    1. Characterization and quantitation of monoamine oxidases A and B in mitochondria from human placenta.
      L A Riley, M A Waguespack and R M Denney
      Molecular Pharmacology July 1989, 36 (1) 54-60;

  2. Waters, J A

    1. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
      C E Spivak, J A Waters and R S Aronstam
      Molecular Pharmacology July 1989, 36 (1) 177-184;

  3. Watkins, P B

    1. Identification of a polymorphically expressed member of the human cytochrome P-450III family.
      S A Wrighton, B J Ring, P B Watkins and M VandenBranden
      Molecular Pharmacology July 1989, 36 (1) 97-105;

  4. Wilkins, D E

    1. Evidence for a pulmonary B3 bradykinin receptor.
      S G Farmer, R M Burch, S A Meeker and D E Wilkins
      Molecular Pharmacology July 1989, 36 (1) 1-8;

  5. Woffendin, C

    1. Permeation and salvage of dideoxyadenosine in mammalian cells.
      P G Plagemann and C Woffendin
      Molecular Pharmacology July 1989, 36 (1) 185-192;

  6. Wrighton, S A

    1. Identification of a polymorphically expressed member of the human cytochrome P-450III family.
      S A Wrighton, B J Ring, P B Watkins and M VandenBranden
      Molecular Pharmacology July 1989, 36 (1) 97-105;

Y

  1. Yamano, S

    1. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.
      S Yamano, T Aoyama, O W McBride, J P Hardwick, H V Gelboin and F J Gonzalez
      Molecular Pharmacology July 1989, 36 (1) 83-88;

  2. Yasumoto, T

    1. Calcium-dependent effects of maitotoxin on phosphoinositide breakdown and on cyclic AMP accumulation in PC12 and NCB-20 cells.
      F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology July 1989, 36 (1) 44-53;

Z

  1. Zhou, Z

    1. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
      J P Sommadossi, R Carlisle and Z Zhou
      Molecular Pharmacology July 1989, 36 (1) 9-14;
Back to top

In this issue

Advertisement